Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma–The predictive significance of B blood group

MK Heenkenda, A Malmström, M Lysiak, M Mudaisi… - Thrombosis research, 2019 - Elsevier
Introduction Venous thromboembolism (VTE) is a common problem among patients with
glioblastoma multiforme (GBM) and with some other cancers. Here, we evaluated genetic …

The need for a vena cava filter in oncological patients with acute venous thrombosis: a marker of a worse prognosis

DBD Leiderman, AE Zerati, MPV Mariz… - Annals of vascular …, 2019 - Elsevier
Background Active cancer is found in approximately 20% of patients diagnosed with venous
thromboembolism. This condition is more prevalent in patients with advanced and metastatic …

[PDF][PDF] FACTOR V LEIDEN AND PROTHROMBIN G20210A GENE MUTATIONS IN CAN-CER PATIENTS WITH THROMBOEMBOLIC EVENTS

KALI KHALIFA, MA HELWA, FI ELBASSAL, SF GOHAR… - researchgate.net
Background: Thrombophilic genes, namely FVL and prothrombin (G20210A) mutations, are
known to increase the risk of VTE in the general population, however their synergistic role …

[PDF][PDF] Interplay between cancer and thrombosis; identification of key factors

B Ünlü - 2019 - scholarlypublications …
Tissue Factor (TF) expression in breast cancer is associated with higher tumor grade,
metastasis and poor survival. TF influences tumor growth through cellular signaling and that …

Тромбоэмболия легочной артерии

ИГ Никитин, ЕВ Резник, ОА Эттингер, ГЕ Гендлин… - 2019 - elibrary.ru
Учебное пособие" Тромбоэмболия легочной артерии" составлено в соответствии с
действующими ФГОС по специальности 31.05. 01—" Лечебное дело" с целью …